Adaptimmune Therapeutics
ADAP
#9245
Rank
NZ$0.12 B
Marketcap
$0.46
Share price
2.86%
Change (1 day)
-76.38%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -NZ$0.12 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are NZ$0.17 Billion. , an increase over its 2023 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.11 Billion-41.87%
2023 -NZ$0.19 Billion-30.65%
2022 -NZ$0.28 Billion-0.36%
2021 -NZ$0.28 Billion21.62%
2020 -NZ$0.23 Billion-4.55%
2019 -NZ$0.24 Billion69%
2018 -NZ$0.14 Billion-7.47%
2017 -NZ$0.15 Billion24.71%
2016 -NZ$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.27 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.74 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.43 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$1.14 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA